Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Treatment
Volume 2015 (2015), Article ID 829696, 8 pages
http://dx.doi.org/10.1155/2015/829696
Research Article

Factors Associated with Opioid Use in a Cohort of Patients Presenting for Surgery

1Division of Pain Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University, Palo Alto, CA, USA
2Stanford Systems Neuroscience and Pain Lab (SNAPL), Stanford University, Palo Alto, CA, USA
3Department of Orthopaedic Surgery, Stanford University, Palo Alto, CA, USA

Received 28 August 2015; Accepted 15 December 2015

Academic Editor: Anna Maria Aloisi

Copyright © 2015 Jennifer M. Hah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Massey, H. N. Dodds, C. S. Roberts, T. J. Servoss, and R. D. Blondell, “Toxicology screening in orthopedic trauma patients predicting duration of prescription opioid use,” Journal of Addictive Diseases, vol. 24, no. 4, pp. 31–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. G. VanDenKerkhof, W. M. Hopman, D. H. Goldstein et al., “Impact of perioperative pain intensity, pain qualities, and opioid use on chronic pain after surgery: a prospective cohort study,” Regional Anesthesia and Pain Medicine, vol. 37, no. 1, pp. 19–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. T. R. Lawrence, N. London, H. H. Bohlman, and K. R. Chin, “Preoperative narcotic use as a predictor of clinical outcome: results following anterior cervical arthrodesis,” Spine, vol. 33, no. 19, pp. 2074–2078, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Raebel, S. R. Newcomer, L. M. Reifler et al., “Chronic use of opioid medications before and after bariatric surgery,” The Journal of the American Medical Association, vol. 310, no. 13, pp. 1369–1376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Pivec, K. Issa, Q. Naziri, B. H. Kapadia, P. M. Bonutti, and M. A. Mont, “Opioid use prior to total hip arthroplasty leads to worse clinical outcomes,” International Orthopaedics, vol. 38, no. 6, pp. 1159–1165, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. M. G. Zywiel, D. A. Stroh, S. Y. Lee, P. M. Bonutti, and M. A. Mont, “Chronic opioid use prior to total knee arthroplasty,” The Journal of Bone & Joint Surgery—American Volume, vol. 93, no. 21, pp. 1988–1993, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. D. Franklin, J. A. Karbassi, W. Li, W. Yang, and D. C. Ayers, “Reduction in narcotic use after primary total knee arthroplasty and association with patient pain relief and satisfaction,” Journal of Arthroplasty, vol. 25, no. 6, pp. 12–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Rapp, L. B. Ready, and M. L. Nessly, “Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review,” Pain, vol. 61, no. 2, pp. 195–201, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Barrantes, F. L. Luan, M. Kommareddi et al., “A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk,” Kidney International, vol. 84, no. 2, pp. 390–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. J. Horvath, R. P. Landry, E. A. Romero-Sandoval, and J. A. DeLeo, “Morphine tolerance attenuates the resolution of postoperative pain and enhances spinal microglial p38 and extracellular receptor kinase phosphorylation,” Neuroscience, vol. 169, no. 2, pp. 843–854, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Liang, X. Shi, Y. Qiao, M. S. Angst, D. C. Yeomans, and J. Clark, “Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision,” Molecular Pain, vol. 4, article 7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. R. Dyer, J. M. White, D. J. R. Foster, F. Bochner, A. Menelaou, and A. A. Somogyi, “The relationship between mood state and plasma methadone concentration in maintenance patients,” Journal of Clinical Psychopharmacology, vol. 21, no. 1, pp. 78–84, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. I. I. Galynker, D. Eisenberg, J. A. Matochik et al., “Cerebral metabolism and mood in remitted opiate dependence,” Drug and Alcohol Dependence, vol. 90, no. 2-3, pp. 166–174, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Savvas, A. A. Somogyi, and J. M. White, “The effect of methadone on emotional reactivity,” Addiction, vol. 107, no. 2, pp. 388–392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Filliol, S. Ghozland, J. Chluba et al., “Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses,” Nature Genetics, vol. 25, no. 2, pp. 195–200, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. T. R. Kosten, C. Morgan, and T. A. Kosten, “Depressive symptoms during buprenorphine treatment of opioid abusers,” Journal of Substance Abuse Treatment, vol. 7, no. 1, pp. 51–54, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. M. O. Rojas-Corrales, E. Berrocoso, J. Gibert-Rahola, and J. A. Micó, “Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats,” Life Sciences, vol. 72, no. 2, pp. 143–152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Doverty, A. A. Somogyi, J. M. White et al., “Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine,” Pain, vol. 93, no. 2, pp. 155–163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Athanasos, C. S. Smith, J. M. White, A. A. Somogyi, F. Bochner, and W. Ling, “Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations,” Pain, vol. 120, no. 3, pp. 267–275, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. A. E. Patanwala, D. L. Jarzyna, M. D. Miller, and B. L. Erstad, “Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty,” Pharmacotherapy, vol. 28, no. 12, pp. 1453–1460, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. L. Ingram, T. A. Macey, E. N. Fossum, and M. M. Morgan, “Tolerance to repeated morphine administration is associated with increased potency of opioid agonists,” Neuropsychopharmacology, vol. 33, no. 10, pp. 2494–2504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Carroll, P. Barelka, C. K. M. Wang et al., “A pilot cohort study of the determinants of longitudinal opioid use after surgery,” Anesthesia & Analgesia, vol. 115, no. 3, pp. 694–702, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Hah, S. Mackey, P. L. Barelka et al., “Self-loathing aspects of depression reduce postoperative opioid cessation rate,” Pain Medicine, vol. 15, no. 6, pp. 954–964, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C. S. Cleeland and K. M. Ryan, “Pain assessment: global use of the Brief Pain Inventory,” Annals of the Academy of Medicine Singapore, vol. 23, no. 2, pp. 129–138, 1994. View at Google Scholar · View at Scopus
  25. S. F. Butler, S. H. Budman, K. Fernandez, and R. N. Jamison, “Validation of a screener and opioid assessment measure for patients with chronic pain,” Pain, vol. 112, no. 1-2, pp. 65–75, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. T. McLellan, L. Luborsky, G. E. Woody, and C. P. O'Brien, “An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index,” The Journal of Nervous and Mental Disease, vol. 168, no. 1, pp. 26–33, 1980. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Mäkelä, “Studies of the reliability and validity of the Addiction Severity Index,” Addiction, vol. 99, no. 4, pp. 398–410, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. D. J. Buysse, C. F. Reynolds III, T. H. Monk, S. R. Berman, and D. J. Kupfer, “The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research,” Psychiatry Research, vol. 28, no. 2, pp. 193–213, 1989. View at Publisher · View at Google Scholar · View at Scopus
  29. A. T. Beck, C. H. Ward, M. Mendelson, J. Mock, and J. Erbaugh, “An inventory for measuring depression,” Archives of General Psychiatry, vol. 4, pp. 561–571, 1961. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Kimerling, P. Ouimette, A. Prins et al., “Brief report: utility of a short screening scale for DSM-IV PTSD in primary care,” Journal of General Internal Medicine, vol. 21, no. 1, pp. 65–67, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Reiss, R. A. Peterson, D. M. Gursky, and R. J. McNally, “Anxiety sensitivity, anxiety frequency and the prediction of fearfulness,” Behaviour Research and Therapy, vol. 24, no. 1, pp. 1–8, 1986. View at Publisher · View at Google Scholar · View at Scopus
  32. D. W. McNeil and A. J. Rainwater III, “Development of the fear of pain questionnaire—III,” Journal of Behavioral Medicine, vol. 21, no. 4, pp. 389–410, 1998. View at Google Scholar
  33. S. F. Butler, K. Fernandez, C. Benoit, S. H. Budman, and R. N. Jamison, “Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R),” The Journal of Pain, vol. 9, no. 4, pp. 360–372, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. F. Butler, S. H. Budman, K. C. Fernandez, G. J. Fanciullo, and R. N. Jamison, “Cross-validation of a screener to predict opioid misuse in chronic pain patients (SOAPP-R),” Journal of Addiction Medicine, vol. 3, no. 2, pp. 66–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Jones, T. Moore, J. L. Levy et al., “A comparison of various risk screening methods in predicting discharge from opioid treatment,” Clinical Journal of Pain, vol. 28, no. 2, pp. 93–100, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. S. D. Passik, A. Narayana, and R. Yang, “Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain,” Pain Medicine, vol. 15, no. 8, pp. 1365–1372, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. S. F. Butler, S. H. Budman, K. C. Fernandez et al., “Development and validation of the current opioid misuse measure,” Pain, vol. 130, no. 1-2, pp. 144–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. D. A. Fishbain, B. Cole, J. E. Lewis, and J. Gao, “What is the evidence for chronic pain being etiologically associated with the DSM-IV category of sleep disorder due to a general medical condition? A structured evidence-based review,” Pain Medicine, vol. 11, no. 2, pp. 158–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. M. D. Stein, D. S. Herman, S. Bishop et al., “Sleep disturbances among methadone maintained patients,” Journal of Substance Abuse Treatment, vol. 26, no. 3, pp. 175–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Zgierska, R. T. Brown, M. Zuelsdorff, D. Brown, Z. Zhang, and M. F. Fleming, “Sleep and daytime sleepiness problems among patients with chronic noncancerous pain receiving long-term opioid therapy: a cross-sectional study,” Journal of Opioid Management, vol. 3, no. 6, pp. 317–327, 2007. View at Google Scholar · View at Scopus
  41. J. M. Walker, R. J. Farney, S. M. Rhondeau et al., “Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing,” Journal of Clinical Sleep Medicine, vol. 3, no. 5, pp. 455–461, 2007. View at Google Scholar · View at Scopus
  42. W. C. Becker, L. E. Sullivan, J. M. Tetrault, R. A. Desai, and D. A. Fiellin, “Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates,” Drug and Alcohol Dependence, vol. 94, no. 1–3, pp. 38–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. M. Liebschutz, R. Saitz, R. D. Weiss et al., “Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain,” Journal of Pain, vol. 11, no. 11, pp. 1047–1055, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Breckenridge and J. D. Clark, “Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain,” Journal of Pain, vol. 4, no. 6, pp. 344–350, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. M. J. Edlund, M. Sullivan, D. Steffick, K. M. Harris, and K. B. Wells, “Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?” Pain Medicine, vol. 8, no. 8, pp. 647–656, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Mailis-Gagnon, S. F. Lakha, T. O. A. Louffat et al., “Chronic noncancer pain: characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic,” Canadian Family Physician, vol. 57, no. 3, pp. e97–e105, 2011. View at Google Scholar · View at Scopus
  47. B. J. Morasco, J. P. Duckart, T. P. Carr, R. A. Deyo, and S. K. Dobscha, “Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain,” Pain, vol. 151, no. 3, pp. 625–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. J. O. Merrill, M. Von Korff, C. J. Banta-Green et al., “Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients,” General Hospital Psychiatry, vol. 34, no. 6, pp. 581–587, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. J. A. Gudin, A. Laitman, and S. Nalamachu, “Opioid related endocrinopathy,” Pain Medicine, vol. 16, supplement 1, pp. S9–S15, 2015. View at Publisher · View at Google Scholar
  50. C. De Maddalena, M. Bellini, M. Berra, M. C. Meriggiola, and A. M. Aloisi, “Opioid-induced hypogonadism: why and how to treat it,” Pain Physician, vol. 15, no. 3, supplement, pp. ES111–ES118, 2012. View at Google Scholar · View at Scopus